Path AI / coverage

About

In 2023, PathAI had a series of announcements to make: the launch of its AISight digital pathology platform and AIM-PD-L1 NSCLC research algorithm, early adoption by leading anatomic pathology laboratories, a research partnership with Cleveland Clinic, and PathExplore, an AI-powered pathology panel for exploring the tumor microenvironment.

SVM’s strategic pitching secured coverage of PathAI’s news in 11 articles across 10 outlets: AIthority, AI-TechPark, Drug Discovery Trends, LabPulse, MobiHealthNews, NXT Life Science, BioPharma Trend, BioSpace, Tissue Pathology, and Stem Cell Science News.

The coverage reached AI, digital health, laboratory, and biopharma audiences as PathAI brought its platform to research and clinical settings.